Alert posted Month-Year | Company | #Alerts | #Win ( > 2%) | #Loss ( < 2% ) | Avg Win% ( > 2%) | #Win ( > 30% ) | Avg Win% ( > 30% ) | Action |
February-2024 | GILD - Gilead Sciences, Inc. | 1 | 1 | 0 | 53.85% | 1 | 53.85% | View Alerts | ROI Analysis |
|
January-2024 | GILD - Gilead Sciences, Inc. | 1 | 1 | 0 | 101.92% | 1 | 101.92% | View Alerts | ROI Analysis |
|
June-2023 | GILD - Gilead Sciences, Inc. | 3 | 2 | 1 | 150.62% | 2 | 150.62% | View Alerts | ROI Analysis |
|
February-2023 | GILD - Gilead Sciences, Inc. | 3 | 2 | 1 | 143.43% | 2 | 143.43% | View Alerts | ROI Analysis |
|
November-2022 | GILD - Gilead Sciences, Inc. | 11 | 8 | 3 | 409.18% | 8 | 409.18% | View Alerts | ROI Analysis |
|
October-2022 | GILD - Gilead Sciences, Inc. | 21 | 18 | 3 | 193.82% | 13 | 260.11% | View Alerts | ROI Analysis |
|
September-2022 | GILD - Gilead Sciences, Inc. | 2 | 2 | 0 | 528.34% | 2 | 528.34% | View Alerts | ROI Analysis |
|
August-2022 | GILD - Gilead Sciences, Inc. | 3 | 3 | 0 | 404.83% | 3 | 404.83% | View Alerts | ROI Analysis |
|
July-2022 | GILD - Gilead Sciences, Inc. | 1 | 1 | 0 | 39.33% | 1 | 39.33% | View Alerts | ROI Analysis |
|
June-2022 | GILD - Gilead Sciences, Inc. | 4 | 4 | 0 | 332.76% | 4 | 332.76% | View Alerts | ROI Analysis |
|
April-2022 | GILD - Gilead Sciences, Inc. | 4 | 4 | 0 | 54.72% | 2 | 94.06% | View Alerts | ROI Analysis |
|
January-2022 | GILD - Gilead Sciences, Inc. | 4 | 4 | 0 | 177.50% | 3 | 227.48% | View Alerts | ROI Analysis |
|
Alert posted Month-Year | Company | #Alerts | #Win ( > 2%) | #Loss ( < 2% ) | Avg Win% ( > 2%) | #Win ( > 30% ) | Avg Win% ( > 30% ) | Action |
December-2021 | GILD - Gilead Sciences, Inc. | 9 | 7 | 2 | 261.53% | 5 | 359.08% | View Alerts | ROI Analysis |
|
November-2021 | GILD - Gilead Sciences, Inc. | 17 | 13 | 4 | 113.04% | 9 | 157.72% | View Alerts | ROI Analysis |
|
October-2021 | GILD - Gilead Sciences, Inc. | 20 | 18 | 2 | 123.47% | 14 | 155.94% | View Alerts | ROI Analysis |
|
August-2021 | GILD - Gilead Sciences, Inc. | 17 | 17 | 0 | 265.23% | 17 | 265.23% | View Alerts | ROI Analysis |
|
July-2021 | GILD - Gilead Sciences, Inc. | 15 | 12 | 3 | 33.08% | 6 | 46.97% | View Alerts | ROI Analysis |
|
June-2021 | GILD - Gilead Sciences, Inc. | 14 | 12 | 2 | 38.44% | 7 | 53.53% | View Alerts | ROI Analysis |
|
May-2021 | GILD - Gilead Sciences, Inc. | 13 | 7 | 6 | 121.47% | 7 | 121.47% | View Alerts | ROI Analysis |
|
April-2021 | GILD - Gilead Sciences, Inc. | 23 | 17 | 6 | 179.43% | 12 | 248.58% | View Alerts | ROI Analysis |
|
March-2021 | GILD - Gilead Sciences, Inc. | 63 | 55 | 8 | 83.01% | 46 | 97.26% | View Alerts | ROI Analysis |
|
February-2021 | GILD - Gilead Sciences, Inc. | 56 | 41 | 15 | 95.43% | 33 | 114.65% | View Alerts | ROI Analysis |
|
January-2021 | GILD - Gilead Sciences, Inc. | 40 | 36 | 4 | 252.61% | 36 | 252.61% | View Alerts | ROI Analysis |
|
December-2020 | GILD - Gilead Sciences, Inc. | 88 | 52 | 36 | 73.54% | 25 | 135.43% | View Alerts | ROI Analysis |
|
Alert posted Month-Year | Company | #Alerts | #Win ( > 2%) | #Loss ( < 2% ) | Avg Win% ( > 2%) | #Win ( > 30% ) | Avg Win% ( > 30% ) | Action |
November-2020 | GILD - Gilead Sciences, Inc. | 82 | 71 | 11 | 99.52% | 55 | 125.20% | View Alerts | ROI Analysis |
|
October-2020 | GILD - Gilead Sciences, Inc. | 119 | 103 | 16 | 242.37% | 71 | 344.31% | View Alerts | ROI Analysis |
|
September-2020 | GILD - Gilead Sciences, Inc. | 100 | 92 | 8 | 143.53% | 68 | 188.05% | View Alerts | ROI Analysis |
|
August-2020 | GILD - Gilead Sciences, Inc. | 108 | 84 | 24 | 89.50% | 55 | 129.19% | View Alerts | ROI Analysis |
|
July-2020 | GILD - Gilead Sciences, Inc. | 133 | 107 | 26 | 144.06% | 80 | 187.99% | View Alerts | ROI Analysis |
|
June-2020 | GILD - Gilead Sciences, Inc. | 139 | 104 | 35 | 86.85% | 66 | 127.71% | View Alerts | ROI Analysis |
|
May-2020 | GILD - Gilead Sciences, Inc. | 126 | 96 | 30 | 79.06% | 69 | 105.63% | View Alerts | ROI Analysis |
|
April-2020 | GILD - Gilead Sciences, Inc. | 154 | 126 | 28 | 216.98% | 107 | 252.76% | View Alerts | ROI Analysis |
|
March-2020 | GILD - Gilead Sciences, Inc. | 198 | 161 | 37 | 261.92% | 143 | 292.47% | View Alerts | ROI Analysis |
|
February-2020 | GILD - Gilead Sciences, Inc. | 107 | 90 | 17 | 328.16% | 84 | 350.39% | View Alerts | ROI Analysis |
|
January-2020 | GILD - Gilead Sciences, Inc. | 32 | 27 | 5 | 235.15% | 22 | 284.40% | View Alerts | ROI Analysis |
|
December-2019 | GILD - Gilead Sciences, Inc. | 23 | 20 | 3 | 154.34% | 20 | 154.34% | View Alerts | ROI Analysis |
|
Alert posted Month-Year | Company | #Alerts | #Win ( > 2%) | #Loss ( < 2% ) | Avg Win% ( > 2%) | #Win ( > 30% ) | Avg Win% ( > 30% ) | Action |
November-2019 | GILD - Gilead Sciences, Inc. | 25 | 20 | 5 | 168.34% | 16 | 205.99% | View Alerts | ROI Analysis |
|
October-2019 | GILD - Gilead Sciences, Inc. | 51 | 32 | 19 | 110.64% | 26 | 132.48% | View Alerts | ROI Analysis |
|
September-2019 | GILD - Gilead Sciences, Inc. | 60 | 43 | 17 | 215.87% | 34 | 268.20% | View Alerts | ROI Analysis |
|
August-2019 | GILD - Gilead Sciences, Inc. | 52 | 38 | 14 | 96.34% | 24 | 145.11% | View Alerts | ROI Analysis |
|
July-2019 | GILD - Gilead Sciences, Inc. | 40 | 28 | 12 | 154.03% | 21 | 198.40% | View Alerts | ROI Analysis |
|
June-2019 | GILD - Gilead Sciences, Inc. | 57 | 47 | 10 | 170.36% | 41 | 193.58% | View Alerts | ROI Analysis |
|
May-2019 | GILD - Gilead Sciences, Inc. | 20 | 13 | 7 | 100.13% | 11 | 116.24% | View Alerts | ROI Analysis |
|
April-2019 | GILD - Gilead Sciences, Inc. | 23 | 20 | 3 | 225.98% | 20 | 225.98% | View Alerts | ROI Analysis |
|
March-2019 | GILD - Gilead Sciences, Inc. | 11 | 9 | 2 | 138.88% | 7 | 172.04% | View Alerts | ROI Analysis |
|
February-2019 | GILD - Gilead Sciences, Inc. | 10 | 9 | 1 | 190.26% | 7 | 239.11% | View Alerts | ROI Analysis |
|
January-2019 | GILD - Gilead Sciences, Inc. | 19 | 16 | 3 | 67.05% | 12 | 85.99% | View Alerts | ROI Analysis |
|
December-2018 | GILD - Gilead Sciences, Inc. | 12 | 7 | 5 | 183.14% | 7 | 183.14% | View Alerts | ROI Analysis |
|
Alert posted Month-Year | Company | #Alerts | #Win ( > 2%) | #Loss ( < 2% ) | Avg Win% ( > 2%) | #Win ( > 30% ) | Avg Win% ( > 30% ) | Action |
November-2018 | GILD - Gilead Sciences, Inc. | 16 | 13 | 3 | 171.81% | 12 | 185.67% | View Alerts | ROI Analysis |
|
October-2018 | GILD - Gilead Sciences, Inc. | 16 | 12 | 4 | 209.77% | 9 | 275.41% | View Alerts | ROI Analysis |
|
September-2018 | GILD - Gilead Sciences, Inc. | 13 | 13 | 0 | 137.74% | 10 | 172.59% | View Alerts | ROI Analysis |
|
August-2018 | GILD - Gilead Sciences, Inc. | 11 | 8 | 3 | 207.43% | 6 | 271.28% | View Alerts | ROI Analysis |
|
July-2018 | GILD - Gilead Sciences, Inc. | 18 | 13 | 5 | 39.23% | 7 | 57.72% | View Alerts | ROI Analysis |
|
June-2018 | GILD - Gilead Sciences, Inc. | 8 | 5 | 3 | 175.66% | 3 | 283.27% | View Alerts | ROI Analysis |
|
May-2018 | GILD - Gilead Sciences, Inc. | 2 | 1 | 1 | 39.66% | 1 | 39.66% | View Alerts | ROI Analysis |
|